BioHealth News
TEDCO Announces FY2025 SBIR/STTR Proposal Lab Cohort
The sixth cohort will undergo the first iteration of the program’s new structure COLUMBIA, Md., (February 13, 2025) — TEDCO, Maryland’s economic engine for…
Read More
Volition: Celebrating women in science: empowering the future
As we celebrate Women in Science Day and Women’s History Month, we are proud to spotlight the women of Volition. From driving groundbreaking innovation…
Read More
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T…
Read More
Maryland Economic Headwinds? Time to Invest in Economies of the Future
By Brian Darmody: While the Maryland economy is facing budget uncertainties, the state can help surmount these challenges by growing private growth industries, converting…
Read More
New GW Study Highlights Importance of Measuring Well-Being in Mental Health Research
New Study Highlights Importance of Measuring Well-Being in Mental Health Research WASHINGTON (February 10, 2025) – A new study published in Nature Mental Health…
Read More
Previous BHCR Crab Trap Winner LifeSprout Completes CE Mark Submission for Lumina™, a Next-Generation Aesthetics Dermal Filler
BALTIMORE, Jan. 23, 2025 /PRNewswire/ -- LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced it has filed for…
Read More
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
GERMANTOWN, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing…
Read More
Investing in BioHealth: Dr. Deborah Hemingway on Building Maryland’s Commercialization Hub on BioTalk
What does it take to establish Maryland as a powerhouse for biotech commercialization? In this episode of BioTalk with Rich Bendis, Dr. Deborah Hemingway, Founder…
Read More
APT – SCOPE Summit 2025: Emmes’ Peter Ronco on Small Biopharma & Clinical Trial Partnerships
In an interview with ACT Associate Editor Don Tracy, Peter Ronco, CEO, Emmes, discusses the "Choosing the Right Allies: Ensuring Clinical Trial Success for…
Read More
Children’s National Hospital and Virginia Tech Expand Research Partnership to Advance Pediatric Health
Newswise — Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established in 2019. This partnership will…
Read More
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
WASHINGTON and SAN DIEGO, Feb. 3, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, global license agreement for the development…
Read More
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous…
Read More
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease progression Top line data…
Read More
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug…
Read More
MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024
MONTGOMERY COUNTY, Md. — Businesses in Maryland’s Montgomery County experienced a surge in investment funding in 2024. Mergers and acquisitions, venture capital and private…
Read More